[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100098418":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":12,"centralContacts":7,"locations":7,"responsibleParty":7,"collaborators":7,"id":16,"slug":17,"hasResults":18,"nctId":19,"briefTitle":20,"officialTitle":21,"acronym":7,"eligibilityCriteria":22,"healthyVolunteers":18,"sex":23,"minAge":24,"maxAge":25,"enrollmentInfo":26,"targetDuration":7,"studyType":29,"phases":30,"briefSummary":32,"conditions":33,"keywords":35,"overallStatus":38,"whyStopped":7,"lastUpdateSubmitDate":39,"lastUpdatePostDateStruct":40,"startDateStruct":43,"completionDateStruct":45,"leadSponsor":47,"locationsCount":7},{"fullName":5,"class":6},"UCB Pharma","INDUSTRY",null,[9],{"type":10,"name":11,"description":7,"armGroupLabels":7,"otherNames":7},"DRUG","levocetirizine dihydrochloride",[13],{"name":14,"affiliation":5,"role":15},"UCb Clinical Trial Call Center","STUDY_DIRECTOR","100098418","phase-4-efficacy-and-safety-of-levocetirizine-and-fexofenadine-in-reducing-symptoms-of-seasonal-allergic-rhinitis-100098418",false,"NCT00542607","Efficacy and Safety of Levocetirizine and Fexofenadine in Reducing Symptoms of Seasonal Allergic Rhinitis","Trial to Compare the Efficacy and Safety of Levocetirizine 5 mg od and Fexofenadine 120 mg od in Reducing Symptoms of Seasonal Allergic Rhinitis in Grass Pollen Sensitized Adults","Inclusion Criteria:\n\n* adults 18 to 55 years both inclusive\n* suffering at least 2 years of seasonal allergic rhinitis due to grass pollen\n* positive RAST and\u002For positive skin prick test\n* comply with study restrictions\n\nExclusion Criteria:\n\n* known alcohol or drug addiction or abuse\n* known allergy\u002Fintolerance to lactose, cellulose, cornstarch\n* presence of nasal anatomical deformities leading to \\> 50% obstruction\n* ENT infection within 30 days of the study\n* use of disallowed medication\n* ongoing desensitization\n* known cardiac, renal or hepatic dysfunction\n* presenting allergic bronchial asthma\n* use of cimetidine\n* intending to donate blood during the trial","ALL","18 Years","55 Years",{"count":27,"type":28},94,"ACTUAL","INTERVENTIONAL",[31],"PHASE4","No information was yet available over the effect of levocetirizine in children under 12 years. The aim of this double-blind, placebo-controlled study was to assess the efficacy and safety of levocetirizine in children from 6 to 12 years old with perennial allergic rhinitis due to house dust mites.",[34],"Rhinitis, Allergic, Seasonal",[36,37],"Levocetirizine dihydrochloride","Xyzal tablets","COMPLETED","2013-12-11",{"date":41,"type":42},"2013-12-12","ESTIMATED",{"date":44,"type":7},"2002-09",{"date":46,"type":28},"2002-12",{"name":5,"class":6}]